New! Sign up for our free email newsletter.
Science News
from research organizations

Whole blood test for toxoplasmosis is sensitive, specific

Date:
August 16, 2018
Source:
PLOS
Summary:
Transmission of toxoplasmosis from mother to fetus can lead to severe congenital problems and fetal death, and tests for the parasitic infection during pregnancy are critical. Now, researchers have showed the efficacy of a low-cost whole blood test for toxoplasmosis.
Share:
FULL STORY

Transmission of toxoplasmosis from mother to fetus can lead to severe congenital problems and fetal death, and tests for the parasitic infection during pregnancy are critical. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed the efficacy of a low-cost whole blood test for toxoplasmosis.

Toxoplasmosis results from infection with the Toxoplasma gondii parasite, usually transmitted to humans from eating undercooked contaminated meat or through exposure to infected cat feces. Existing tests for the infection are serum tests, which require blood samples to be processed using infrastructure and technology which can be prohibitive in developing areas and unaffordable in developed countries like the United States.

Rima McLeod of the University of Chicago and her colleagues, including Joseph Lykins and Karen Leahy, tested 205 individuals. The individuals tested included patients, volunteers, and obstetrical patients from Chicago and Morocco known to be infected with T. gondii. A team led by coauthor Dr. El Bissati tested the pregnant patients in Morocco, and Dr. McLeod's team tested the patients in Chicago. The blood was tested for T. gondii infection status using reference tests, standard-of-care serum tests and the new whole-blood point-of-care (POC) test obtained by finger stick.

The whole blood POC test had 100% agreement with the reference and serum-variant testing, and proved highly sensitive and specific, with a sensitivity of 100% and a specificity of 100%. The scores held true even for women with lower levels of anti-Toxoplasma antibodies. However, the test cannot distinguish between acute and chronic infections.

The authors note, "Our work establishes a new point of care test in the outpatient setting at very low cost enabling diagnosis and prompt treatment for toxoplasma infections acquired for the first time during pregnancy. This enables life, sight and cognition saving treatments. If combined with multiplexed testing for other congenital infections and markers associated with premature birth, it will markedly improve maternal child outcomes and save lives."


Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.


Journal Reference:

  1. Joseph Lykins, Xuan Li, Pauline Levigne, Ying Zhou, Kamal El Bissati, Fatima Clouser, Martine Wallon, Florence Morel, Karen Leahy, Bouchra El Mansouri, Maryam Siddiqui, Nicole Leong, Morgan Michalowski, Erin Irwin, Perpetua Goodall, Mahmoud Ismail, Monica Christmas, El Bachir Adlaoui, Mohamed Rhajaoui, Amina Barkat, Hua Cong, Ian J. Begeman, Bo Shiun Lai, Despina G. Contopoulos-Ioannidis, Jose G. Montoya, Yvonne Maldonado, Raymund Ramirez, Cindy Press, Francois Peyron, Rima McLeod. Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies. PLOS Neglected Tropical Diseases, 2018; 12 (8): e0006536 DOI: 10.1371/journal.pntd.0006536

Cite This Page:

PLOS. "Whole blood test for toxoplasmosis is sensitive, specific." ScienceDaily. ScienceDaily, 16 August 2018. <www.sciencedaily.com/releases/2018/08/180816143243.htm>.
PLOS. (2018, August 16). Whole blood test for toxoplasmosis is sensitive, specific. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2018/08/180816143243.htm
PLOS. "Whole blood test for toxoplasmosis is sensitive, specific." ScienceDaily. www.sciencedaily.com/releases/2018/08/180816143243.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES